Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

NeoTX Acquires Israeli Drug Discovery Firm InterX.

Document Cited in Related
Vincent

MANews-(C)2009-2022

Israeli clinical-stage company NeoTX has acquired US-based drug discovery firm InterX, the company said.

InterX, is a drug discovery company utilizing advanced proprietary tools of biomolecular computation for the discovery and design of novel therapeutic molecules based on Nobel Prize Laureate Prof Michael Levitt's discoveries.

These tools allow a detailed quantum mechanical process assessment of biochemical interactions resulting in faster, more accurate and efficient drug discovery.

In addition to the discovery engine, this acquisition also comes with a pipeline of early drugs.

NeoTX is a clinical-stage company developing targeted anticancer immunotherapies utilizing its proprietary Tumor Targeted Superantigen platform.

TTS binds a genetically engineered bacterial determinant to the tumor surface while simultaneously activating and expanding tumor specific immune cells that are then...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT